Big bucks for infrastructure in latest ARC round
Friday, 04 October, 2002
Life science related infrastructure projects have been funded to the tune of nearly $10.5 million in the latest round of Australian Research Council linkage, infrastructure and equipment (LIEF) grants.
The grants range in size from $100,000 for a quantitative PCR facility based at the University of New England, to a massive $1.584 million fillip awarded to a consortium of five NSW and ACT universities for a NMR spectrometer for molecular structure function analysis.
The LIEF grant scheme is designed to encourage research institutions to collaborate, develop research infrastructures and form large-scale cooperative initiatives.
Notable recipients in the latest round include:
- A grant of $500,000 to a group headed by Prof Perry Bartlett of the university of Queensland, Griffith University and Queensland University of Technology to develop a cell sorter facility for neuroscience and related biotechnology.
- $630,000 for a joint facility for plant genetic analysis and gene discovery in WA, headed by Prof Mike Jones and colleagues at Murdoch University and the University of WA.
- A grant of $500,000 for the developmenmt of a South Australian supercomputing facility, whose partners include the University of Adelaide, Flinders University, the University of South Australia and Northern Territory University.
- $630,000 for a functional genomics analysis facility to improve DNA analysis and data management between five universities in the Sydney and Newcastle area.
- $218,000 for the establishment of the Adelaide Mass Spectrometry Facility, involving the University of Adelaide, Flinders University, the Institute for Medical and veterinary Science and TGR Biosciences.
- A grant of $400,000 for a high-performance computing and web facility for genome bioinformatics between the University of Queensland and QUT.
Cancer drug eliminates bone metastasis in lab models
Researchers have developed a novel treatment that is specific to breast cancer bone metastasis...
TGA rejects Alzheimer's drug due to safety concerns
The TGA determined that the demonstrated efficacy of lecanemab in treating Alzheimer's did...
Defective sperm doubles pre-eclampsia risk in IVF patients
A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...